{
    "references": [
        {
            "bibentry": "Part CLIV in the series of Azinyl Sulphides.",
            "process_entry": "True",
            "xmlid": "CIT0099"
        },
        {
            "bibentry": "Torre, L, Siegel, R, Jemal, A Global cancer facts and figures. 3rd ed. USA: American Cancer Society. 2015 Available from https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/global-cancer-facts-and-figures/global-cancer-facts-and-figures-3rd-edition.pdf",
            "process_entry": "True",
            "url": "https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/global-cancer-facts-and-figures/global-cancer-facts-and-figures-3rd-edition.pdf",
            "xmlid": "CIT0001"
        },
        {
            "bibentry": "Siegel, RL, Miller, KD, Jemal, A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5–29. PMID: 25559415",
            "process_entry": "True",
            "doi": "10.3322/caac.21254",
            "pmid": "25559415",
            "xmlid": "CIT0002"
        },
        {
            "bibentry": "Nussbaumer, S, Bonnabry, P, Veuthey, J-L, Fleury-Souverain, S. Analysis of anticancer drugs: a review. Talanta 2011; 85: 2265–89. PMID: 21962644",
            "process_entry": "True",
            "doi": "10.1016/j.talanta.2011.08.034",
            "pmid": "21962644",
            "xmlid": "CIT0003"
        },
        {
            "bibentry": "Lundqvist, E, Fujiwara, K, Seoud, M. Principles of chemotherapy. Int J Gynecol Obstet 2015; 131: S146–S9.",
            "process_entry": "True",
            "xmlid": "CIT0004"
        },
        {
            "bibentry": "Bajaj, S, Asati, V, Singh, J, Roy, PP. 1,3,4-Oxadiazoles: an emerging scaffold to target growth factors, enzymes and kinases as anticancer agents. Eur J Med Chem 2015; 97: 124–41. PMID: 25965776",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2015.04.051",
            "pmid": "25965776",
            "xmlid": "CIT0005"
        },
        {
            "bibentry": "Yugandhar, D, Nayak, VL, Archana, S, et al. Design, synthesis and anticancer properties of novel oxa/azaspiro[4,5]trienones as potent apoptosis inducers through mitochondrial disruption. Eur J Med Chem 2015; 101: 348–57. PMID: 26163220",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2015.06.050",
            "pmid": "26163220",
            "xmlid": "CIT0006"
        },
        {
            "bibentry": "Gupta, RR, Kumar, M. Synthesis, properties and reactions of phenothiazines In: Gupta RR, editor. Phenothiazine and 1,4-benzothiazines –chemical and biological aspect. Amsterdam: Elsevier; 1988: 1–161.",
            "process_entry": "True",
            "xmlid": "CIT0007"
        },
        {
            "bibentry": "Mosnaim, AD, Ranade, VV, Wolf, ME, et al. Phenothiazine molecule provides the basic chemical structure for various classes of pharmacotherapeutic agents. Am J Ther 2006; 13: 261–73. PMID: 16772768",
            "process_entry": "True",
            "doi": "10.1097/01.mjt.0000212897.20458.63",
            "pmid": "16772768",
            "xmlid": "CIT0008"
        },
        {
            "bibentry": "Amaral, L, Viveiros, M. Thioridazine: a non-antibiotic drug highly effective, in combination with first line anti-tuberculosis drugs, against any form of antibiotic resistance of mycobacterium tuberculosis due to its multi-mechanisms of action. Antibiotics 2017; 6: 3–14.",
            "process_entry": "True",
            "xmlid": "CIT0009"
        },
        {
            "bibentry": "Yue, H, Huang, D, Qin, L, et al. Targeting lung cancer stem cells with antipsychological drug thioridazine. BioMed Res Int 2016; 3: 1–7.",
            "process_entry": "True",
            "xmlid": "CIT0010"
        },
        {
            "bibentry": "Motohashi, N, Kawase, M, Satoh, K, Sakagami, H. Cytotoxic potential of phenothiazines. Curr Drug Targets 2006; 7: 1055–66. PMID: 17017885",
            "process_entry": "True",
            "doi": "10.2174/138945006778226624",
            "pmid": "17017885",
            "xmlid": "CIT0011"
        },
        {
            "bibentry": "Mitchell, SC. Phenothiazine: the parent molecule. Curr Drug Targets 2006; 7: 1181–9. PMID: 17017893",
            "process_entry": "True",
            "doi": "10.2174/138945006778226552",
            "pmid": "17017893",
            "xmlid": "CIT0012"
        },
        {
            "bibentry": "Dasgupta, A, Dastridara, SG, Shirataki, Y, Motohashi, N. Antibacterial activity of artificial phenothiazines and isoflavones from plants In, Motohashi, N, ed. Bioactive Heterocycles VI. Topics in Heterocyclic Chemistry. vol 15 Berlin, Heidelberg: Springer; 2008: 67–132.",
            "process_entry": "True",
            "xmlid": "CIT0013"
        },
        {
            "bibentry": "Aaron, JJ, Gaye Seye, MD, Trajkovska, S, Motohashi, N. Bioactive phenothiazines and Benzo[a]phenothiazines: spectroscopic studies and biological and biomedical properties and applications In, Motohashi, N, ed. Bioactive Heterocycles VII. Topics in Heterocyclic Chemistry. vol 16 Berlin, Heidelberg: Springer; 2009: 153–231.",
            "process_entry": "True",
            "xmlid": "CIT0014"
        },
        {
            "bibentry": "Sadandam, YS, Shetty, MM, Bhaskar Rao, A. 10H-Phenothiazines: a new class of enzyme inhibitors for inflammatory diseases. Eur J Med Chem 2009; 44: 197–202. PMID: 18400337",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2008.02.028",
            "pmid": "18400337",
            "xmlid": "CIT0015"
        },
        {
            "bibentry": "Pluta, K, Morak-Młodawska, B, Jeleń, M. Recent progress in biological activities of synthesized phenothiazines. Eur J Med Chem 2011; 46: 3179–89. PMID: 21620536",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2011.05.013",
            "pmid": "21620536",
            "xmlid": "CIT0016"
        },
        {
            "bibentry": "Sudeshna, G, Parimal, K. Multiple non-psychiatric effects of phenothiazines: a review. Eur J Pharmacol 2010; 648: 6–14. PMID: 20828548",
            "process_entry": "True",
            "doi": "10.1016/j.ejphar.2010.08.045",
            "pmid": "20828548",
            "xmlid": "CIT0017"
        },
        {
            "bibentry": "Wesołowska, O. Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1. Acta Biochim Pol 2011; 58: 433–48. PMID: 22187677",
            "process_entry": "True",
            "pmid": "22187677",
            "xmlid": "CIT0018"
        },
        {
            "bibentry": "Jaszczyszyn, A, Gąsiorowski, K, Świątek, P, et al. Chemical structure of phenothiazines and their biological activity. Pharmacol Rep 2012; 64: 16–23. PMID: 22580516",
            "process_entry": "True",
            "doi": "10.1016/s1734-1140(12)70726-0",
            "pmid": "22580516",
            "xmlid": "CIT0019"
        },
        {
            "bibentry": "Pluta, K, Jeleń, M, Morak-Młodawska, B, et al. Azaphenothiazines a promising phenothiazine derivatives. An insight into nomenclature, synthesis, structure elucidation and biological properties. Eur J Med Chem 2017; 138: 774–806. PMID: 28734245",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2017.07.009",
            "pmid": "28734245",
            "xmlid": "CIT0020"
        },
        {
            "bibentry": "Amaral, L, Kristiansen, JE. Phenothiazines: potential management of Creutzfeldt-Jacob disease and its variants. Int J Antimicrob Agents 2001; 18: 411–7. PMID: 11711254",
            "process_entry": "True",
            "doi": "10.1016/s0924-8579(01)00432-0",
            "pmid": "11711254",
            "xmlid": "CIT0021"
        },
        {
            "bibentry": "González-Muñoz, GC, Arce, MP, López, B, et al. Old phenothiazine and dibenzothiadiazepine derivatives for tomorrow’s neuroprotective therapies against neurodegenerative diseases. Eur J Med Chem 2010; 45: 6152–8. PMID: 20926162",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2010.09.039",
            "pmid": "20926162",
            "xmlid": "CIT0022"
        },
        {
            "bibentry": "González-Muñoz, GC, Arce, MP, López, B, et al. N-Acylamino-phenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer’s disease. Eur J Med Chem 2011; 46: 2224–35. PMID: 21420206",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2011.03.003",
            "pmid": "21420206",
            "xmlid": "CIT0023"
        },
        {
            "bibentry": "Uhrig, S, Hirth, N, Broccoli, L, et al. Reduced oxytocin receptor gene expression and binding sites in different brain regions in schizophrenia: a post-mortem study. Schizophrenia Res 2016; 117: 59–66.",
            "process_entry": "True",
            "xmlid": "CIT0024"
        },
        {
            "bibentry": "Winkler, D, Pjrek, E, Lanzenberger, R, et al. Actigraphy in patients with treatment-resistant depression undergoing electroconvulsive therapy. J Psychiatr Res 2014; 57: 96–100. PMID: 24998016",
            "process_entry": "True",
            "doi": "10.1016/j.jpsychires.2014.06.006",
            "pmid": "24998016",
            "xmlid": "CIT0025"
        },
        {
            "bibentry": "Kleinmann, A, Schrader, V, Stübner, S, et al. Psychopharmacological treatment of 1650 in-patients with acute mania-data from the AMSP study. J Affect Disord 2016; 191: 164–71. PMID: 26655125",
            "process_entry": "True",
            "doi": "10.1016/j.jad.2015.11.037",
            "pmid": "26655125",
            "xmlid": "CIT0026"
        },
        {
            "bibentry": "Moreau, A, Dompmartin, A, Dubreuil, A, Leroy, D. Phototoxic and photoprotective effects of topical isothipendyl. Photodermatol Photoimmunol Photomed 1995; 11: 50–4. PMID: 8546983",
            "process_entry": "True",
            "doi": "10.1111/j.1600-0781.1995.tb00139.x",
            "pmid": "8546983",
            "xmlid": "CIT0027"
        },
        {
            "bibentry": "Shaikh, SMT, Seetharamappa, J, Kandagal, PB, Ashoka, S. Binding of the bioactive component isothipendyl hydrochloride with bovine serum albumin. J Mol Struct 2006; 786: 46–52.",
            "process_entry": "True",
            "xmlid": "CIT0028"
        },
        {
            "bibentry": "Amin, AS, El-Sheikh, R, Zahran, F, El-fetough Gouda, AA. Spectrophotometric determination of pipazethate HCl, dextromethorphan HBr and drotaverine HCl in their pharmaceutical preparations. Spectrochim Acta A Mol Biomol Spectrosc 2007; 67: 1088–93. PMID: 17092767",
            "process_entry": "True",
            "doi": "10.1016/j.saa.2006.09.027",
            "pmid": "17092767",
            "xmlid": "CIT0029"
        },
        {
            "bibentry": "O’Neil, MJ, ed. The Merck Index. An encyclopedia of chemicals, drugs, and biologicals. 14th ed Whitehouse Station, NJ: Merck & Co, Inc; 2006: 6972.",
            "process_entry": "True",
            "xmlid": "CIT0030"
        },
        {
            "bibentry": "Okafor, C, Castle, R. Synthesis of analogues of the 2,3,6-triazaphenothiazine ring system. J Heterocycl Chem 1983; 20: 199–203.",
            "process_entry": "True",
            "xmlid": "CIT0031"
        },
        {
            "bibentry": "Werle, E, Kopp, E, Leysath, G. Die Antihistaminwirkung von 2,7-diazaphenothiazin und einiger seiner derivate. Arzneim-Forsch 1962; 4: 443–4.",
            "process_entry": "True",
            "xmlid": "CIT0032"
        },
        {
            "bibentry": "Morak-Młodawska, B, Pluta, K, Zimecki, M, et al. Synthesis and selected immunological properties of 10-substituted 1,8-diazaphenothiazines. Med Chem Res 2015; 24: 1408–18. PMID: 25750499",
            "process_entry": "True",
            "doi": "10.1007/s00044-014-1220-9",
            "pmid": "25750499",
            "pmcid": "PMC4344556",
            "xmlid": "CIT0033"
        },
        {
            "bibentry": "Morak-Młodawska, B, Pluta, K, Latocha, M, Jeleń, M. Synthesis, spectroscopic characterization and anticancer activity of new 10-substituted 1,6-diazaphenothiazines. Med Chem Res 2016; 25: 2425–33. PMID: 27818603",
            "process_entry": "True",
            "doi": "10.1007/s00044-016-1646-3",
            "pmid": "27818603",
            "pmcid": "PMC5075014",
            "xmlid": "CIT0034"
        },
        {
            "bibentry": "Morak-Młodawska, B, Pluta, K, Latocha, M, et al. 3,6-Diazaphenothiazines as potential lead molecules –synthesis, characterization and anticancer activity. J Enzyme Inhib Med Chem 2016; 31: 1512–219. PMID: 26950280",
            "process_entry": "True",
            "doi": "10.3109/14756366.2016.1151014",
            "pmid": "26950280",
            "xmlid": "CIT0035"
        },
        {
            "bibentry": "Morak-Młodawska, B, Pluta, K, Latocha, M, et al. Synthesis and anticancer and lipophilic properties of 10-dialkylaminobutynyl derivatives of 1,8-and 2,7-diazaphenothiazines. J Enzyme Inhib Med Chem 2016; 31: 1132–8. PMID: 27677322",
            "process_entry": "True",
            "doi": "10.3109/14756366.2015.1101092",
            "pmid": "27677322",
            "xmlid": "CIT0036"
        },
        {
            "bibentry": "Zimecki, M, Artym, J, Kocięba, M, et al. Immunosupressive activities of newly synthesized azaphenothiazines in human and mouse models. Cell Mol Biol Lett 2009; 14: 622–35. PMID: 19557312",
            "process_entry": "True",
            "doi": "10.2478/s11658-009-0025-1",
            "pmid": "19557312",
            "pmcid": "PMC6275713",
            "xmlid": "CIT0037"
        },
        {
            "bibentry": "Pluta, K, Jeleń, M, Morak-Młodawska, B, et al. Anticancer activity of newly synthesized azaphenothiazines in NCI’s anticancer screening. Pharmacol Rep 2010; 62: 319–32. PMID: 20508288",
            "process_entry": "True",
            "doi": "10.1016/s1734-1140(10)70272-3",
            "pmid": "20508288",
            "xmlid": "CIT0038"
        },
        {
            "bibentry": "Zhang, J, Chen, M, Wenzhi, Z, et al. 10H-3,6-diazaphenothiazines induce G 2/M phase cell cycle arrest, caspase-dependent apoptosis and inhibits cell invasion of A2780 ovarian carcinoma cells through regulation on NF-κB and [BIRC6-XIAP] complexes. Drug Des Develop Ther 2017; 11: 3045–63.",
            "process_entry": "True",
            "xmlid": "CIT0039"
        },
        {
            "bibentry": "Rath. Dimethylaminopropyldipyridothiazane S. US Patent 2,789,978; 1957.",
            "process_entry": "True",
            "xmlid": "CIT0040"
        },
        {
            "bibentry": "Maki, Y. Sulfur-containing pyridine derivatives. LIII. Smiles rearrangement in pyridine derivatives and synthesis of azaphenothiazine derivatives. Yakugaku Zasshi 1957; 77: 485–90.",
            "process_entry": "True",
            "xmlid": "CIT0041"
        },
        {
            "bibentry": "Takahashi, T, Maki, Y. Sulfur-containing pyridine derivatives. LVI. Smiles rearrangement of pyridine derivatives and synthesis of benzopyrido-and dipyrido-1, 4-thiazine derivatives. Chem Pharm Bull 1958; 6: 369–73. PMID: 13585510",
            "process_entry": "True",
            "doi": "10.1248/cpb.6.369",
            "pmid": "13585510",
            "xmlid": "CIT0042"
        },
        {
            "bibentry": "Rodig, O, Collier, R, Schlatzer, R. Pyridine chemistry. I. The smiles rearrangement of the 3-amino-2,2’-dipyridyl sulfide system. J Org Chem 1964; 29: 2652–8.",
            "process_entry": "True",
            "xmlid": "CIT0043"
        },
        {
            "bibentry": "Rodig, O, Collier, R, Schlatzer, R. Pyridine chemistry. II. Further studies on the smiles rearrangement of the 3-amino-2,2’-dipyridyl sulfide system. The synthesis of some 1,6-diazaphenothiazines. J Med Chem 1966; 9: 116–20. PMID: 5958938",
            "process_entry": "True",
            "doi": "10.1021/jm00319a028",
            "pmid": "5958938",
            "xmlid": "CIT0044"
        },
        {
            "bibentry": "Morak-Młodawska, B, Pluta, K, Suwińska, K, Jeleń, M. The double smiles rearrangement in neutral conditions leading to one of 10-(nitropyridinyl)dipyridothiazine isomers. J Mol Struct 2017; 1133: 398–404.",
            "process_entry": "True",
            "xmlid": "CIT0045"
        },
        {
            "bibentry": "Morak-Młodawska, B, Suwińska, K, Pluta, K, Jeleń, M. 10-(3’-Nitro-4’-pyridyl)-1,8-diazaphenothiazine as the double Smiles rearrangement product. J Mol Struct 2012; 1015: 94–8.",
            "process_entry": "True",
            "xmlid": "CIT0046"
        },
        {
            "bibentry": "Morak, B, Pluta, K, Suwińska, K. Unexpected simple route to novel dipyrido-1,4-thiazines. Heterocyclic Commun 2002; 8: 331–4.",
            "process_entry": "True",
            "xmlid": "CIT0047"
        },
        {
            "bibentry": "Morak, B, Pluta, K. Synthesis of novel dipyrido-1,4-thiazines. Heterocycles 2007; 71: 1347–61.",
            "process_entry": "True",
            "xmlid": "CIT0048"
        },
        {
            "bibentry": "Okafor, CO. Heterocyclic series. I. A novel diazaphenothiazine system. J Org Chem 1967; 32: 2006–7.",
            "process_entry": "True",
            "xmlid": "CIT0049"
        },
        {
            "bibentry": "Pluta, K, Morak-Młodawska, B, Jeleń, M. Synthesis and properties of diaza, triaza-and tetraazaphenothiazines. J Heterocycl Chem 2009; 46: 355–91.",
            "process_entry": "True",
            "xmlid": "CIT0050"
        },
        {
            "bibentry": "Kopp, E, Strell, M. Űber 2,7-diazaphenothiazin. Arch Pharm 1962; 295: 99–106.",
            "process_entry": "True",
            "xmlid": "CIT0051"
        },
        {
            "bibentry": "Morak-Młodawska, B, Suwińska, K, Pluta, K, Jeleń, M. Alkylations of 10H-2,7-diazaphenothiazine to alkyl-2,7-diazaphenothiazinium salts and 7-alkyl-2,7-diazaphenothiazines. Heterocycles 2010; 81: 2511–22.",
            "process_entry": "True",
            "xmlid": "CIT0052"
        },
        {
            "bibentry": "Allen, MA, Andrysik, Z, Dengler, VL, et al. Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms. ELife 2014; 3: e02200(1-29). PMID: 24867637",
            "process_entry": "True",
            "doi": "10.7554/eLife.02200",
            "pmid": "24867637",
            "pmcid": "PMC4033189",
            "xmlid": "CIT0053"
        },
        {
            "bibentry": "Grant, PA. A tale of histone modifications. Genome Biol 2001; 2: 1–6.",
            "process_entry": "True",
            "xmlid": "CIT0054"
        },
        {
            "bibentry": "Giui, CY, Ngo, L, Xu, WS, et al. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc Natl Acad Sci USA 2004; 101: 1241–6. PMID: 14734806",
            "process_entry": "True",
            "doi": "10.1073/pnas.0307708100",
            "pmid": "14734806",
            "pmcid": "PMC337037",
            "xmlid": "CIT0055"
        },
        {
            "bibentry": "Riley, T, Sontag, E, Chen, P, Levine, A. Transcriptional control of human 53-regulated genes. Nat Rev Mol Cell Biol 2008; 9: 402–12. PMID: 18431400",
            "process_entry": "True",
            "doi": "10.1038/nrm2395",
            "pmid": "18431400",
            "xmlid": "CIT0056"
        },
        {
            "bibentry": "Idogawa, M, Ohashi, T, Sasaki, Y, et al. Identification and analysis of large intergenic non-coding RNAs regulated by p53 family members through a genome-wide analysis of p53-binding sites. Hum Mol Genet 2014; 23: 2847–57. PMID: 24403050",
            "process_entry": "True",
            "doi": "10.1093/hmg/ddt673",
            "pmid": "24403050",
            "xmlid": "CIT0057"
        },
        {
            "bibentry": "Dutto, I, Tillhon, M, Cazzalini, O, et al. Biology of the cell cycle inhibitor p21 CDKN1A: molecular, mechanisms and relevance in chemical toxicology. Arch Toxicol 2015; 89: 155–78. PMID: 25514883",
            "process_entry": "True",
            "doi": "10.1007/s00204-014-1430-4",
            "pmid": "25514883",
            "xmlid": "CIT0058"
        },
        {
            "bibentry": "Wei1, C-Y, Tan, Q-X, Zhu, X, et al. Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance. Int J Clin Exp Pathol 2015; 8: 14619–29. PMID: 26823785",
            "process_entry": "True",
            "pmid": "26823785",
            "pmcid": "PMC4713571",
            "xmlid": "CIT0059"
        },
        {
            "bibentry": "Elmore, S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495–516. PMID: 17562483",
            "process_entry": "True",
            "doi": "10.1080/01926230701320337",
            "pmid": "17562483",
            "pmcid": "PMC2117903",
            "xmlid": "CIT0060"
        },
        {
            "bibentry": "Parida, PK, Mahata, B, Santra, A, et al. Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis. Cell Death Dis 2018; 9: 448. PMID: 29670107",
            "process_entry": "True",
            "doi": "10.1038/s41419-018-0476-2",
            "pmid": "29670107",
            "pmcid": "PMC5906627",
            "xmlid": "CIT0061"
        },
        {
            "bibentry": "Martinez-Ruiz, G, Maldonado, V, Ceballos-Cancino, G, et al. Role of Smac/DIABLO in cancer progression. J Exp Clin Cancer Res 2008; 27: 48–7. PMID: 18822137",
            "process_entry": "True",
            "doi": "10.1186/1756-9966-27-48",
            "pmid": "18822137",
            "pmcid": "PMC2566557",
            "xmlid": "CIT0062"
        },
        {
            "bibentry": "Arntzen, MØ, Thiede, B. ApoptoProteomics, an integrated database for analysis of proteomics data obtained from apoptotic cells. Mol Cell Proteomics 2012; 11: M111.010447.",
            "process_entry": "True",
            "xmlid": "CIT0063"
        }
    ],
    "localid": "MED-31307242",
    "doi": "10.1080/14756366.2019.1639695",
    "pmid": "10.1080/14756366.2019.1639695",
    "pmcid": "31307242",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/31307242/fullTextXML",
    "reference_pointers": [
        [
            {
                "n_rp": 0,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),119,106)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 1,
                "xref_id": "CIT0002",
                "rp_string": "2",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),119,106)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 6,
                "xref_id": "CIT0001",
                "rp_string": "1–4",
                "pl_string": "1–4",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),360,153)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 3,
                "xref_id": "",
                "pl_string": "1–4",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),360,153)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 4,
                "xref_id": "",
                "pl_string": "1–4",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),360,153)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 5,
                "xref_id": "",
                "pl_string": "1–4",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),360,153)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 6,
                "xref_id": "CIT0001",
                "rp_string": "1–4",
                "pl_string": "1–4",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),360,153)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 7,
                "xref_id": "CIT0005",
                "rp_string": "5",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,163)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 8,
                "xref_id": "CIT0006",
                "rp_string": "6",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,163)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 9,
                "xref_id": "CIT0007",
                "rp_string": "7",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),165,109)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 10,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),402,236)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 11,
                "xref_id": "CIT0009",
                "rp_string": "9",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),639,325)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 12,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),243,289)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 23,
                "xref_id": "CIT0011",
                "rp_string": "11–20",
                "pl_string": "11–20",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),243,289)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 14,
                "xref_id": "",
                "pl_string": "11–20",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),243,289)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 15,
                "xref_id": "",
                "pl_string": "11–20",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),243,289)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 16,
                "xref_id": "",
                "pl_string": "11–20",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),243,289)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 17,
                "xref_id": "",
                "pl_string": "11–20",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),243,289)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 18,
                "xref_id": "",
                "pl_string": "11–20",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),243,289)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 19,
                "xref_id": "",
                "pl_string": "11–20",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),243,289)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 20,
                "xref_id": "",
                "pl_string": "11–20",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),243,289)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 21,
                "xref_id": "",
                "pl_string": "11–20",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),243,289)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 22,
                "xref_id": "",
                "pl_string": "11–20",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),243,289)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 23,
                "xref_id": "CIT0011",
                "rp_string": "11–20",
                "pl_string": "11–20",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),243,289)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 24,
                "xref_id": "CIT0008",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),533,270)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 28,
                "xref_id": "CIT0021",
                "rp_string": "21–23",
                "pl_string": "21–23",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),533,270)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 26,
                "xref_id": "",
                "pl_string": "21–23",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),533,270)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 27,
                "xref_id": "",
                "pl_string": "21–23",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),533,270)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 28,
                "xref_id": "CIT0021",
                "rp_string": "21–23",
                "pl_string": "21–23",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),533,270)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 32,
                "xref_id": "CIT0024",
                "rp_string": "24–26",
                "pl_string": "The modifications of the phenothiazine structure with one or two pyridine rings lead to pyridobenzothiazines and dipyridothiazines, respectively. Of the four isomeric pyridobenzothiazines (being 1-aza-, 2-aza-, 3-aza- and 4-azaphenothiazines), the 10-dialkylaminoalkyl derivatives of the 1-aza series (known as prothipendyl, isothipendyl, oxypendyl, cloxypendyl and pipazethate) are still used in the various therapies such as antipsychotic24–26, antihistaminic27,28, and antitussive29 and antiemetic drugs30.",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),147,363)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 30,
                "xref_id": "",
                "pl_string": "24–26",
                "pl_xpath": "/article/body/sec[1]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),147,363)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 31,
                "xref_id": "",
                "pl_string": "24–26",
                "pl_xpath": "/article/body/sec[1]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),147,363)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 32,
                "xref_id": "CIT0024",
                "rp_string": "24–26",
                "pl_string": "The modifications of the phenothiazine structure with one or two pyridine rings lead to pyridobenzothiazines and dipyridothiazines, respectively. Of the four isomeric pyridobenzothiazines (being 1-aza-, 2-aza-, 3-aza- and 4-azaphenothiazines), the 10-dialkylaminoalkyl derivatives of the 1-aza series (known as prothipendyl, isothipendyl, oxypendyl, cloxypendyl and pipazethate) are still used in the various therapies such as antipsychotic24–26, antihistaminic27,28, and antitussive29 and antiemetic drugs30.",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),147,363)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 33,
                "xref_id": "CIT0027",
                "rp_string": "27",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),147,363)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "The modifications of the phenothiazine structure with one or two pyridine rings lead to pyridobenzothiazines and dipyridothiazines, respectively. Of the four isomeric pyridobenzothiazines (being 1-aza-, 2-aza-, 3-aza- and 4-azaphenothiazines), the 10-dialkylaminoalkyl derivatives of the 1-aza series (known as prothipendyl, isothipendyl, oxypendyl, cloxypendyl and pipazethate) are still used in the various therapies such as antipsychotic24–26, antihistaminic27,28, and antitussive29 and antiemetic drugs30.",
                "pl_xpath": "/article/body/sec[1]/p[4]"
            },
            {
                "n_rp": 34,
                "xref_id": "CIT0028",
                "rp_string": "28",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),147,363)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "The modifications of the phenothiazine structure with one or two pyridine rings lead to pyridobenzothiazines and dipyridothiazines, respectively. Of the four isomeric pyridobenzothiazines (being 1-aza-, 2-aza-, 3-aza- and 4-azaphenothiazines), the 10-dialkylaminoalkyl derivatives of the 1-aza series (known as prothipendyl, isothipendyl, oxypendyl, cloxypendyl and pipazethate) are still used in the various therapies such as antipsychotic24–26, antihistaminic27,28, and antitussive29 and antiemetic drugs30.",
                "pl_xpath": "/article/body/sec[1]/p[4]"
            },
            {
                "n_rp": 35,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),147,363)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "The modifications of the phenothiazine structure with one or two pyridine rings lead to pyridobenzothiazines and dipyridothiazines, respectively. Of the four isomeric pyridobenzothiazines (being 1-aza-, 2-aza-, 3-aza- and 4-azaphenothiazines), the 10-dialkylaminoalkyl derivatives of the 1-aza series (known as prothipendyl, isothipendyl, oxypendyl, cloxypendyl and pipazethate) are still used in the various therapies such as antipsychotic24–26, antihistaminic27,28, and antitussive29 and antiemetic drugs30.",
                "pl_xpath": "/article/body/sec[1]/p[4]"
            },
            {
                "n_rp": 36,
                "xref_id": "CIT0030",
                "rp_string": "30",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),147,363)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "The modifications of the phenothiazine structure with one or two pyridine rings lead to pyridobenzothiazines and dipyridothiazines, respectively. Of the four isomeric pyridobenzothiazines (being 1-aza-, 2-aza-, 3-aza- and 4-azaphenothiazines), the 10-dialkylaminoalkyl derivatives of the 1-aza series (known as prothipendyl, isothipendyl, oxypendyl, cloxypendyl and pipazethate) are still used in the various therapies such as antipsychotic24–26, antihistaminic27,28, and antitussive29 and antiemetic drugs30.",
                "pl_xpath": "/article/body/sec[1]/p[4]"
            }
        ],
        [
            {
                "n_rp": 37,
                "xref_id": "CIT0031",
                "rp_string": "31",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),196,137)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 45,
                "xref_id": "CIT0033",
                "rp_string": "33–39",
                "pl_string": "33–39",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[3]",
                "pl_xpath": "/article/body/sec[1]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),334,252)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 39,
                "xref_id": "",
                "pl_string": "33–39",
                "pl_xpath": "/article/body/sec[1]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),334,252)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 40,
                "xref_id": "",
                "pl_string": "33–39",
                "pl_xpath": "/article/body/sec[1]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),334,252)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 41,
                "xref_id": "",
                "pl_string": "33–39",
                "pl_xpath": "/article/body/sec[1]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),334,252)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 42,
                "xref_id": "",
                "pl_string": "33–39",
                "pl_xpath": "/article/body/sec[1]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),334,252)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 43,
                "xref_id": "",
                "pl_string": "33–39",
                "pl_xpath": "/article/body/sec[1]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),334,252)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 44,
                "xref_id": "",
                "pl_string": "33–39",
                "pl_xpath": "/article/body/sec[1]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),334,252)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 45,
                "xref_id": "CIT0033",
                "rp_string": "33–39",
                "pl_string": "33–39",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[3]",
                "pl_xpath": "/article/body/sec[1]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),334,252)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 46,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),587,145)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 47,
                "xref_id": "CIT0037",
                "rp_string": "37",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),587,145)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 48,
                "xref_id": "CIT0038",
                "rp_string": "38",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),587,145)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 49,
                "xref_id": "CIT0037",
                "rp_string": "37",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),733,214)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 50,
                "xref_id": "CIT0039",
                "rp_string": "39",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),948,164)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 51,
                "xref_id": "CIT0040",
                "rp_string": "40",
                "rp_xpath": "/article/body/sec[1]/p[6]/xref",
                "context_xpath": "substring(string(/article/body/sec[1]/p[6]),246,169)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 52,
                "xref_id": "CIT0034",
                "rp_string": "34",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),429,137)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ],
                "pl_string": "Synthesis of known dipyridothiazines is dependent on the location of the nitrogen atoms in the formed products. Synthesis from aminonitrodipyridinyl (2,2′-, 2,4′- and 4,4′-) sulphides or from two appropriate disubstituted pyridines (proceeding through a sulphide formation step without isolation) runs as the Smiles rearrangement to dipyridinylamine (usually not isolated) followed by cyclisation to form the 1,4-thiazine ring. In this way, four dipyridothiazines were obtained (1,6-diaza-34,41–45, 1,8-diaza-33,46, 2,7-diaza-47,48 and 3,6-diazaphenothiazines35,49. Direct cyclisation as the Ullmann-type process to 2,6-diaza-, 2,8-diaza- and 4,6-diazaphenothiazines has not been observed50. Symmetrical 1,9-diaza- and 3,7-diazaphenothiazines were obtained by sulphurisation of 2,2′- and 4,4′-dipyridinylamine with elemental sulphur at higher temperature. The synthesis of 10H-1,9-diazaphenothiazine (2) was mentioned by Rath40 as a procedure of preparation being similar to the process used for converting diphenylamine to phenothiazine (without any details of the reaction conditions, and the product isolation and characterisation). The synthesis of isomeric 10H-3,7-diazaphenothiazine in the reaction of sulphurisation of 4,4′-dipyridinylamine was performed at 280–290 °C giving the product in very yield (9%)51.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]"
            },
            {
                "n_rp": 60,
                "xref_id": "CIT0041",
                "rp_string": "41–45",
                "pl_string": "Synthesis of known dipyridothiazines is dependent on the location of the nitrogen atoms in the formed products. Synthesis from aminonitrodipyridinyl (2,2′-, 2,4′- and 4,4′-) sulphides or from two appropriate disubstituted pyridines (proceeding through a sulphide formation step without isolation) runs as the Smiles rearrangement to dipyridinylamine (usually not isolated) followed by cyclisation to form the 1,4-thiazine ring. In this way, four dipyridothiazines were obtained (1,6-diaza-34,41–45, 1,8-diaza-33,46, 2,7-diaza-47,48 and 3,6-diazaphenothiazines35,49. Direct cyclisation as the Ullmann-type process to 2,6-diaza-, 2,8-diaza- and 4,6-diazaphenothiazines has not been observed50. Symmetrical 1,9-diaza- and 3,7-diazaphenothiazines were obtained by sulphurisation of 2,2′- and 4,4′-dipyridinylamine with elemental sulphur at higher temperature. The synthesis of 10H-1,9-diazaphenothiazine (2) was mentioned by Rath40 as a procedure of preparation being similar to the process used for converting diphenylamine to phenothiazine (without any details of the reaction conditions, and the product isolation and characterisation). The synthesis of isomeric 10H-3,7-diazaphenothiazine in the reaction of sulphurisation of 4,4′-dipyridinylamine was performed at 280–290 °C giving the product in very yield (9%)51.",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[2]",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),429,137)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ]
            },
            {
                "n_rp": 54,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),429,137)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ],
                "pl_string": "Synthesis of known dipyridothiazines is dependent on the location of the nitrogen atoms in the formed products. Synthesis from aminonitrodipyridinyl (2,2′-, 2,4′- and 4,4′-) sulphides or from two appropriate disubstituted pyridines (proceeding through a sulphide formation step without isolation) runs as the Smiles rearrangement to dipyridinylamine (usually not isolated) followed by cyclisation to form the 1,4-thiazine ring. In this way, four dipyridothiazines were obtained (1,6-diaza-34,41–45, 1,8-diaza-33,46, 2,7-diaza-47,48 and 3,6-diazaphenothiazines35,49. Direct cyclisation as the Ullmann-type process to 2,6-diaza-, 2,8-diaza- and 4,6-diazaphenothiazines has not been observed50. Symmetrical 1,9-diaza- and 3,7-diazaphenothiazines were obtained by sulphurisation of 2,2′- and 4,4′-dipyridinylamine with elemental sulphur at higher temperature. The synthesis of 10H-1,9-diazaphenothiazine (2) was mentioned by Rath40 as a procedure of preparation being similar to the process used for converting diphenylamine to phenothiazine (without any details of the reaction conditions, and the product isolation and characterisation). The synthesis of isomeric 10H-3,7-diazaphenothiazine in the reaction of sulphurisation of 4,4′-dipyridinylamine was performed at 280–290 °C giving the product in very yield (9%)51.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]"
            },
            {
                "n_rp": 55,
                "xref_id": "CIT0046",
                "rp_string": "46",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),429,137)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ],
                "pl_string": "Synthesis of known dipyridothiazines is dependent on the location of the nitrogen atoms in the formed products. Synthesis from aminonitrodipyridinyl (2,2′-, 2,4′- and 4,4′-) sulphides or from two appropriate disubstituted pyridines (proceeding through a sulphide formation step without isolation) runs as the Smiles rearrangement to dipyridinylamine (usually not isolated) followed by cyclisation to form the 1,4-thiazine ring. In this way, four dipyridothiazines were obtained (1,6-diaza-34,41–45, 1,8-diaza-33,46, 2,7-diaza-47,48 and 3,6-diazaphenothiazines35,49. Direct cyclisation as the Ullmann-type process to 2,6-diaza-, 2,8-diaza- and 4,6-diazaphenothiazines has not been observed50. Symmetrical 1,9-diaza- and 3,7-diazaphenothiazines were obtained by sulphurisation of 2,2′- and 4,4′-dipyridinylamine with elemental sulphur at higher temperature. The synthesis of 10H-1,9-diazaphenothiazine (2) was mentioned by Rath40 as a procedure of preparation being similar to the process used for converting diphenylamine to phenothiazine (without any details of the reaction conditions, and the product isolation and characterisation). The synthesis of isomeric 10H-3,7-diazaphenothiazine in the reaction of sulphurisation of 4,4′-dipyridinylamine was performed at 280–290 °C giving the product in very yield (9%)51.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]"
            },
            {
                "n_rp": 56,
                "xref_id": "CIT0047",
                "rp_string": "47",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),429,137)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ],
                "pl_string": "Synthesis of known dipyridothiazines is dependent on the location of the nitrogen atoms in the formed products. Synthesis from aminonitrodipyridinyl (2,2′-, 2,4′- and 4,4′-) sulphides or from two appropriate disubstituted pyridines (proceeding through a sulphide formation step without isolation) runs as the Smiles rearrangement to dipyridinylamine (usually not isolated) followed by cyclisation to form the 1,4-thiazine ring. In this way, four dipyridothiazines were obtained (1,6-diaza-34,41–45, 1,8-diaza-33,46, 2,7-diaza-47,48 and 3,6-diazaphenothiazines35,49. Direct cyclisation as the Ullmann-type process to 2,6-diaza-, 2,8-diaza- and 4,6-diazaphenothiazines has not been observed50. Symmetrical 1,9-diaza- and 3,7-diazaphenothiazines were obtained by sulphurisation of 2,2′- and 4,4′-dipyridinylamine with elemental sulphur at higher temperature. The synthesis of 10H-1,9-diazaphenothiazine (2) was mentioned by Rath40 as a procedure of preparation being similar to the process used for converting diphenylamine to phenothiazine (without any details of the reaction conditions, and the product isolation and characterisation). The synthesis of isomeric 10H-3,7-diazaphenothiazine in the reaction of sulphurisation of 4,4′-dipyridinylamine was performed at 280–290 °C giving the product in very yield (9%)51.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]"
            },
            {
                "n_rp": 57,
                "xref_id": "CIT0048",
                "rp_string": "48",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),429,137)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ],
                "pl_string": "Synthesis of known dipyridothiazines is dependent on the location of the nitrogen atoms in the formed products. Synthesis from aminonitrodipyridinyl (2,2′-, 2,4′- and 4,4′-) sulphides or from two appropriate disubstituted pyridines (proceeding through a sulphide formation step without isolation) runs as the Smiles rearrangement to dipyridinylamine (usually not isolated) followed by cyclisation to form the 1,4-thiazine ring. In this way, four dipyridothiazines were obtained (1,6-diaza-34,41–45, 1,8-diaza-33,46, 2,7-diaza-47,48 and 3,6-diazaphenothiazines35,49. Direct cyclisation as the Ullmann-type process to 2,6-diaza-, 2,8-diaza- and 4,6-diazaphenothiazines has not been observed50. Symmetrical 1,9-diaza- and 3,7-diazaphenothiazines were obtained by sulphurisation of 2,2′- and 4,4′-dipyridinylamine with elemental sulphur at higher temperature. The synthesis of 10H-1,9-diazaphenothiazine (2) was mentioned by Rath40 as a procedure of preparation being similar to the process used for converting diphenylamine to phenothiazine (without any details of the reaction conditions, and the product isolation and characterisation). The synthesis of isomeric 10H-3,7-diazaphenothiazine in the reaction of sulphurisation of 4,4′-dipyridinylamine was performed at 280–290 °C giving the product in very yield (9%)51.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]"
            },
            {
                "n_rp": 58,
                "xref_id": "CIT0035",
                "rp_string": "35",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),429,137)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ],
                "pl_string": "Synthesis of known dipyridothiazines is dependent on the location of the nitrogen atoms in the formed products. Synthesis from aminonitrodipyridinyl (2,2′-, 2,4′- and 4,4′-) sulphides or from two appropriate disubstituted pyridines (proceeding through a sulphide formation step without isolation) runs as the Smiles rearrangement to dipyridinylamine (usually not isolated) followed by cyclisation to form the 1,4-thiazine ring. In this way, four dipyridothiazines were obtained (1,6-diaza-34,41–45, 1,8-diaza-33,46, 2,7-diaza-47,48 and 3,6-diazaphenothiazines35,49. Direct cyclisation as the Ullmann-type process to 2,6-diaza-, 2,8-diaza- and 4,6-diazaphenothiazines has not been observed50. Symmetrical 1,9-diaza- and 3,7-diazaphenothiazines were obtained by sulphurisation of 2,2′- and 4,4′-dipyridinylamine with elemental sulphur at higher temperature. The synthesis of 10H-1,9-diazaphenothiazine (2) was mentioned by Rath40 as a procedure of preparation being similar to the process used for converting diphenylamine to phenothiazine (without any details of the reaction conditions, and the product isolation and characterisation). The synthesis of isomeric 10H-3,7-diazaphenothiazine in the reaction of sulphurisation of 4,4′-dipyridinylamine was performed at 280–290 °C giving the product in very yield (9%)51.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]"
            },
            {
                "n_rp": 59,
                "xref_id": "CIT0049",
                "rp_string": "49",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),429,137)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ],
                "pl_string": "Synthesis of known dipyridothiazines is dependent on the location of the nitrogen atoms in the formed products. Synthesis from aminonitrodipyridinyl (2,2′-, 2,4′- and 4,4′-) sulphides or from two appropriate disubstituted pyridines (proceeding through a sulphide formation step without isolation) runs as the Smiles rearrangement to dipyridinylamine (usually not isolated) followed by cyclisation to form the 1,4-thiazine ring. In this way, four dipyridothiazines were obtained (1,6-diaza-34,41–45, 1,8-diaza-33,46, 2,7-diaza-47,48 and 3,6-diazaphenothiazines35,49. Direct cyclisation as the Ullmann-type process to 2,6-diaza-, 2,8-diaza- and 4,6-diazaphenothiazines has not been observed50. Symmetrical 1,9-diaza- and 3,7-diazaphenothiazines were obtained by sulphurisation of 2,2′- and 4,4′-dipyridinylamine with elemental sulphur at higher temperature. The synthesis of 10H-1,9-diazaphenothiazine (2) was mentioned by Rath40 as a procedure of preparation being similar to the process used for converting diphenylamine to phenothiazine (without any details of the reaction conditions, and the product isolation and characterisation). The synthesis of isomeric 10H-3,7-diazaphenothiazine in the reaction of sulphurisation of 4,4′-dipyridinylamine was performed at 280–290 °C giving the product in very yield (9%)51.",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]"
            }
        ],
        [
            {
                "n_rp": 60,
                "xref_id": "CIT0041",
                "rp_string": "41–45",
                "pl_string": "Synthesis of known dipyridothiazines is dependent on the location of the nitrogen atoms in the formed products. Synthesis from aminonitrodipyridinyl (2,2′-, 2,4′- and 4,4′-) sulphides or from two appropriate disubstituted pyridines (proceeding through a sulphide formation step without isolation) runs as the Smiles rearrangement to dipyridinylamine (usually not isolated) followed by cyclisation to form the 1,4-thiazine ring. In this way, four dipyridothiazines were obtained (1,6-diaza-34,41–45, 1,8-diaza-33,46, 2,7-diaza-47,48 and 3,6-diazaphenothiazines35,49. Direct cyclisation as the Ullmann-type process to 2,6-diaza-, 2,8-diaza- and 4,6-diazaphenothiazines has not been observed50. Symmetrical 1,9-diaza- and 3,7-diazaphenothiazines were obtained by sulphurisation of 2,2′- and 4,4′-dipyridinylamine with elemental sulphur at higher temperature. The synthesis of 10H-1,9-diazaphenothiazine (2) was mentioned by Rath40 as a procedure of preparation being similar to the process used for converting diphenylamine to phenothiazine (without any details of the reaction conditions, and the product isolation and characterisation). The synthesis of isomeric 10H-3,7-diazaphenothiazine in the reaction of sulphurisation of 4,4′-dipyridinylamine was performed at 280–290 °C giving the product in very yield (9%)51.",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[2]",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),429,137)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ]
            },
            {
                "n_rp": 61,
                "xref_id": "",
                "pl_string": "41–45",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),429,137)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ]
            },
            {
                "n_rp": 62,
                "xref_id": "",
                "pl_string": "41–45",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),429,137)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ]
            },
            {
                "n_rp": 63,
                "xref_id": "",
                "pl_string": "41–45",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),429,137)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ]
            },
            {
                "n_rp": 64,
                "xref_id": "",
                "pl_string": "41–45",
                "pl_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),429,137)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ]
            }
        ],
        [
            {
                "n_rp": 65,
                "xref_id": "CIT0050",
                "rp_string": "50",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),567,125)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ]
            }
        ],
        [
            {
                "n_rp": 66,
                "xref_id": "CIT0040",
                "rp_string": "40",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[10]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),857,279)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ]
            }
        ],
        [
            {
                "n_rp": 67,
                "xref_id": "CIT0051",
                "rp_string": "51",
                "rp_xpath": "/article/body/sec[3]/sec[1]/p[1]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[1]/p[1]),1137,180)",
                "containers_title": [
                    "Results and discussion",
                    "Synthesis"
                ]
            }
        ],
        [
            {
                "n_rp": 68,
                "xref_id": "CIT0040",
                "rp_string": "40",
                "rp_xpath": "/article/body/sec[3]/sec[2]/p[1]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[1]),1,48)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic analysis"
                ]
            }
        ],
        [
            {
                "n_rp": 69,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[3]/sec[2]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[2]/p[3]),81,151)",
                "containers_title": [
                    "Results and discussion",
                    "Spectroscopic analysis"
                ]
            }
        ],
        [
            {
                "n_rp": 70,
                "xref_id": "CIT0035",
                "rp_string": "35",
                "rp_xpath": "/article/body/sec[3]/sec[3]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/p[3]),1,155)",
                "containers_title": [
                    "Results and discussion",
                    "X-ray diffraction study"
                ]
            }
        ],
        [
            {
                "n_rp": 71,
                "xref_id": "CIT0047",
                "rp_string": "47",
                "rp_xpath": "/article/body/sec[3]/sec[3]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/p[3]),1,155)",
                "containers_title": [
                    "Results and discussion",
                    "X-ray diffraction study"
                ]
            }
        ],
        [
            {
                "n_rp": 72,
                "xref_id": "CIT0052",
                "rp_string": "52",
                "rp_xpath": "/article/body/sec[3]/sec[3]/p[3]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[3]/p[3]),1,155)",
                "containers_title": [
                    "Results and discussion",
                    "X-ray diffraction study"
                ]
            }
        ],
        [
            {
                "n_rp": 76,
                "xref_id": "CIT0033",
                "rp_string": "33–35",
                "pl_string": "33–35",
                "rp_xpath": "/article/body/sec[3]/sec[4]/p/xref[1]",
                "pl_xpath": "/article/body/sec[3]/sec[4]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[4]/p),224,138)",
                "containers_title": [
                    "Results and discussion",
                    "Anticancer activity"
                ]
            },
            {
                "n_rp": 74,
                "xref_id": "",
                "pl_string": "33–35",
                "pl_xpath": "/article/body/sec[3]/sec[4]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[4]/p),224,138)",
                "containers_title": [
                    "Results and discussion",
                    "Anticancer activity"
                ]
            },
            {
                "n_rp": 75,
                "xref_id": "",
                "pl_string": "33–35",
                "pl_xpath": "/article/body/sec[3]/sec[4]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[4]/p),224,138)",
                "containers_title": [
                    "Results and discussion",
                    "Anticancer activity"
                ]
            }
        ],
        [
            {
                "n_rp": 76,
                "xref_id": "CIT0033",
                "rp_string": "33–35",
                "pl_string": "33–35",
                "rp_xpath": "/article/body/sec[3]/sec[4]/p/xref[1]",
                "pl_xpath": "/article/body/sec[3]/sec[4]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[4]/p),224,138)",
                "containers_title": [
                    "Results and discussion",
                    "Anticancer activity"
                ]
            }
        ],
        [
            {
                "n_rp": 77,
                "xref_id": "CIT0038",
                "rp_string": "38",
                "rp_xpath": "/article/body/sec[3]/sec[4]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[4]/p),224,138)",
                "containers_title": [
                    "Results and discussion",
                    "Anticancer activity"
                ]
            }
        ],
        [
            {
                "n_rp": 78,
                "xref_id": "CIT0039",
                "rp_string": "39",
                "rp_xpath": "/article/body/sec[3]/sec[4]/p/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[4]/p),224,138)",
                "containers_title": [
                    "Results and discussion",
                    "Anticancer activity"
                ]
            }
        ],
        [
            {
                "n_rp": 79,
                "xref_id": "CIT0053",
                "rp_string": "53",
                "rp_xpath": "/article/body/sec[3]/sec[5]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/p[2]),287,106)",
                "containers_title": [
                    "Results and discussion",
                    "Apoptosis assay"
                ]
            }
        ],
        [
            {
                "n_rp": 80,
                "xref_id": "CIT0054",
                "rp_string": "54",
                "rp_xpath": "/article/body/sec[3]/sec[5]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/p[2]),287,106)",
                "containers_title": [
                    "Results and discussion",
                    "Apoptosis assay"
                ]
            }
        ],
        [
            {
                "n_rp": 81,
                "xref_id": "CIT0055",
                "rp_string": "55",
                "rp_xpath": "/article/body/sec[3]/sec[5]/p[3]/sup/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/p[3]),280,134)",
                "containers_title": [
                    "Results and discussion",
                    "Apoptosis assay"
                ],
                "pl_string": "55–57",
                "pl_xpath": "/article/body/sec[3]/sec[5]/p[3]/sup"
            },
            {
                "n_rp": 82,
                "xref_id": "CIT0057",
                "rp_string": "57",
                "rp_xpath": "/article/body/sec[3]/sec[5]/p[3]/sup/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/p[3]),280,134)",
                "containers_title": [
                    "Results and discussion",
                    "Apoptosis assay"
                ],
                "pl_string": "55–57",
                "pl_xpath": "/article/body/sec[3]/sec[5]/p[3]/sup"
            }
        ],
        [
            {
                "n_rp": 84,
                "xref_id": "",
                "pl_string": "55–57",
                "pl_xpath": "/article/body/sec[3]/sec[5]/p[3]/sup",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/p[3]),280,134)",
                "containers_title": [
                    "Results and discussion",
                    "Apoptosis assay"
                ]
            }
        ],
        [
            {
                "n_rp": 84,
                "xref_id": "",
                "pl_string": "55–57",
                "pl_xpath": "/article/body/sec[3]/sec[5]/p[3]/sup",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/p[3]),280,134)",
                "containers_title": [
                    "Results and discussion",
                    "Apoptosis assay"
                ]
            }
        ],
        [
            {
                "n_rp": 85,
                "xref_id": "CIT0058",
                "rp_string": "58",
                "rp_xpath": "/article/body/sec[3]/sec[5]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/p[4]),473,112)",
                "containers_title": [
                    "Results and discussion",
                    "Apoptosis assay"
                ]
            }
        ],
        [
            {
                "n_rp": 86,
                "xref_id": "CIT0059",
                "rp_string": "59",
                "rp_xpath": "/article/body/sec[3]/sec[5]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/p[4]),473,112)",
                "containers_title": [
                    "Results and discussion",
                    "Apoptosis assay"
                ]
            }
        ],
        [
            {
                "n_rp": 87,
                "xref_id": "CIT0060",
                "rp_string": "60",
                "rp_xpath": "/article/body/sec[3]/sec[5]/p[5]/xref",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/p[5]),264,200)",
                "containers_title": [
                    "Results and discussion",
                    "Apoptosis assay"
                ]
            }
        ],
        [
            {
                "n_rp": 88,
                "xref_id": "CIT0061",
                "rp_string": "61",
                "rp_xpath": "/article/body/sec[3]/sec[5]/p[8]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/p[8]),290,275)",
                "containers_title": [
                    "Results and discussion",
                    "Apoptosis assay"
                ]
            }
        ],
        [
            {
                "n_rp": 89,
                "xref_id": "CIT0062",
                "rp_string": "62",
                "rp_xpath": "/article/body/sec[3]/sec[5]/p[8]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/p[8]),665,188)",
                "containers_title": [
                    "Results and discussion",
                    "Apoptosis assay"
                ]
            }
        ],
        [
            {
                "n_rp": 90,
                "xref_id": "CIT0063",
                "rp_string": "63",
                "rp_xpath": "/article/body/sec[3]/sec[5]/p[8]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/sec[5]/p[8]),854,167)",
                "containers_title": [
                    "Results and discussion",
                    "Apoptosis assay"
                ]
            }
        ]
    ]
}